My Next Health (“MNH”) is an innovative healthcare company with a vision to improve the global healthcare sector by deploying an innovative genomic-based AI and quantum platform for clinical trials, point of care solutions and personalized consumer health.
MNH’s proprietary insights focus on how systems of genes interact with each other as well as with epigenetic factors (e.g, environment, lifestyle, nutrition, etc.) to drive key metabolic pathways. These discoveries are based on over 15,000 case studies conducted by the Company’s Chief Scientific Officer, Dr. Mansoor Mohammed, a renowned geneticist whose research collaboration leading to the discovery of copy number variation in genetics was short-listed for a Noble Prize in Physiology/Medicine.
MNH insights are being scaled through a tier 1 generative AI platform, that will leverage key exponential technologies including quantum computing, to revolutionize personalized healthcare through drug discovery and development, point of care solutions and consumer applications.
MNH Business Lines
- CLINICAL STUDIES AND TRIALS
- HEALTHCARE PROVIDER SOLUTIONS
- PERSONALIZED HEALTH PLATFORM
The public version will be available at www.mynexthealth.com.
Overview
OUR VISION
To improve human health by accelerating the world’s transition to precision medicine.
OUR MISSION
To advance the healthcare and wellness sectors through genomics, generative AI and quantum computing.
A Revolutionary Approach to Healthcare Through the New Paradigm of Actionable Genomics
My Next Health (“MNH”) is an innovative healthcare company with a vision to improve the global healthcare sector by deploying an innovative genomic-based AI and quantum platform for clinical trials, point of care solutions and personalized consumer health.
MNH’s proprietary insights focus on how systems of genes interact with each other as well as with epigenetic factors (e.g, environment, lifestyle, nutrition, etc.) to drive key metabolic pathways. These discoveries are based on over 15,000 case studies conducted by the Company’s Chief Scientific Officer, Dr. Mansoor Mohammed, a renowned geneticist whose research collaboration leading to the discovery of copy number variation in genetics was short-listed for a Noble Prize in Physiology/Medicine.
MNH insights are being scaled through a tier 1 generative AI platform, that will leverage key exponential technologies including quantum computing, to revolutionize personalized healthcare through drug discovery and development, point of care solutions and consumer applications.
MNH Business Lines
- CLINICAL STUDIES AND TRIALS
- HEALTHCARE PROVIDER SOLUTIONS
- PERSONALIZED HEALTH PLATFORM
The public version will be available at www.mynexthealth.com.
Overview
OUR VISION
To improve human health by accelerating the world’s transition to precision medicine.
OUR MISSION
To advance the healthcare and wellness sectors through genomics, generative AI and quantum computing.